Clinical Trial Update: A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of basmisanil in cognitive impairment associated with schizophrenia in patients treated with antipsychotics has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Basmisanil (basmisanil)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-09